Literature DB >> 10458928

Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.

C L Grosskreutz1, B Anand-Apte, C Dupláa, T P Quinn, B I Terman, B Zetter, P A D'Amore.   

Abstract

Angiogenesis is a complex process that includes recruitment and proliferation of mural cells-smooth muscle cells (SMC) and pericytes. Vascular endothelial growth factor (VEGF) has been shown to play an important role in angiogenesis and is an endothelial cell chemoattractant. In addition, certain VEGF isoforms have been implicated in the normal formation of smooth muscle cell-surrounded arteries. Because VEGF's role as a mural cell chemoattractant had not been explored, we examined the ability of VEGF to influence vascular SMC migration in vitro. A Boyden chamber migration assay demonstrated that VEGF (0-100 ng/ml) caused a dose-dependent migration of SMC. VEGF did not cause proliferation of SMC. Reverse transcriptase-polymerase chain reaction analysis demonstrated the presence of both KDR and flt mRNA, two known VEGF receptors, in SMC cultures. Western blot analysis of SMC lysates confirmed these data, revealing bands migrating at approximately 200 kDa and slightly below 200 kDa consistent with KDR and flt. These observations demonstrate that VEGF receptors are present on SMC, and that VEGF can act as an SMC chemoattractant. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458928     DOI: 10.1006/mvre.1999.2171

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  43 in total

1.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

Authors:  C Sundberg; J A Nagy; L F Brown; D Feng; I A Eckelhoefer; E J Manseau; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Alginate Sulfates Mitigate Binding Kinetics of Proangiogenic Growth Factors with Receptors toward Revascularization.

Authors:  John Schmidt; Min Kyung Lee; Eunkyung Ko; Jae Hyun Jeong; Luisa A DiPietro; Hyunjoon Kong
Journal:  Mol Pharm       Date:  2016-02-29       Impact factor: 4.939

3.  Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair.

Authors:  Detlev Roth; Michael Piekarek; Mats Paulsson; Hildegard Christ; Wilhelm Bloch; Thomas Krieg; Jeffrey M Davidson; Sabine A Eming
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 4.  Spatiotemporal control over growth factor signaling for therapeutic neovascularization.

Authors:  Lan Cao; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

Review 5.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

6.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

Review 7.  Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery.

Authors:  Tatiana N Demidova-Rice; Michael R Hamblin; Ira M Herman
Journal:  Adv Skin Wound Care       Date:  2012-08       Impact factor: 2.347

8.  A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization.

Authors:  Scott M Damrauer; Mark D Fisher; Hiromi Wada; Jeffrey J Siracuse; Cleide G da Silva; Karam Moon; Eva Csizmadia; Elizabeth R Maccariello; Virendra I Patel; Peter Studer; Sanah Essayagh; William C Aird; Soizic Daniel; Christiane Ferran
Journal:  Atherosclerosis       Date:  2010-04-04       Impact factor: 5.162

9.  Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma.

Authors:  Nibal Zaghloul; Sonia L Hernandez; Jae-O Bae; Jianzhong Huang; Jason C Fisher; Alice Lee; Angela Kadenhe-Chiweshe; Jessica J Kandel; Darrell J Yamashiro
Journal:  Int J Oncol       Date:  2009-02       Impact factor: 5.650

10.  VEGF Receptor-2-Linked PI3K/Calpain/SIRT1 Activation Mediates Retinal Arteriolar Dilations to VEGF and Shear Stress.

Authors:  Travis W Hein; Robert H Rosa; Yi Ren; Wenjuan Xu; Lih Kuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.